Entrada Therapeutics, Inc. · NASDAQ:TRDA

Janus Henderson Group PLC reported a 5.60% stake in Entrada Therapeutics, Inc. (Schedule 13G/A)

Event Mar 31, 2025 · Filed May 14, 2025

Janus Henderson Group PLC reported a 5.60% stake in Entrada Therapeutics, Inc., 2,121,654 shares, as a passive investor on Mar 31, 2025. Filed May 14, 2025 (Schedule 13G/A).

Stake
5.60%
Shares
2,121,654
Intent
Passive
What changed
Stake changed
Filed together
2 holders

The filing in full

HolderStakeShares
JANUS HENDERSON GROUP PLC5.60%2,121,654
Janus Henderson Biotech Innovation Master Fund Ltd5.00%1,884,826

Source

View original at SEC

Related